Overview:
The management of gastrointestinal malignancies is challenging and complex, incorporating a team-based approach to diagnosis, assessment, and treatment. Rapidly and accurately interpreting new clinical findings from publications and large meetings is paramount to keeping pace with the latest best practices, but many clinicians find themselves struggling to remain updated on these new data.
This live, virtual symposium brings together experts in the management of gastrointestinal cancer to discuss key data from recent scientific congresses, placing them in the context of current practice and how they’re likely to inform or change management of these cancers.
Learning Objectives
Upon completion of this activity, participants will be able to:
- Assess recent trials’ study designs, including patient characteristics, and outcomes
- Summarize efficacy and safety findings from trials evaluating novel strategies for the management of gastrointestinal cancers.
- Interpret clinical trial results in the context of evolving care paradigms in gastrointestinal cancers’ management
Target Audience
This educational activity is directed toward oncologists, pathologists, nurses, NPs/PAs, and other Healthcare Providers who manage patients with GI cancers
Benefits of Attending
- Hear the latest from the European GI meeting
- Place new findings into the context of your practice
- Get your burning clinical questions answered by world experts in GI cancer research
Hot Topics
- Targeted therapy for biomarker-driven GI cancers
- Immunotherapy for hepatobiliary cancers
- Novel chemotherapy regimens
Zev Wainberg, MD
Co-Director UCLA Gastro-Intestinal Oncology Program;
Medical Director, UCLA Colorectal Cancer Center;
Assistant Professor of Medicine
Division of Hematology Oncology,
David Geffen School of Medicine at UCLA
Los Angeles, CA
Teresa M. Macarulla, MD, PhD
Vall D'Hebron Institute Of Oncology
Barcelona, Spain
Eric Van Cutsem, MD, PhD
Chief of Digestive Oncology
University Hospitals Gasthuisberg Leuven (UZ Leuven)
University of Leuven (KUL).University Hospitals Leuven
Leuven, Belgium
| Oncology Town Hall™: Live Report from Barcelona for Advances in the Treatment of GI Cancers |
|||||
| Time | Duration | End Time | Title | ||
| 12:00 PM | 0:05 | 12:05 PM | Welcome and Introduction | ||
| 12:05 PM | 0:26 | 12:31 PM | Data Presentations on Colorectal Cancer | ||
| 12:31 PM | 0:27 | 12:58 PM | Data Presentations on Hepatobiliary and Pancreas Cancer | ||
| 12:58 PM | 0:27 | 1:25 PM | Data Presentations on Esophagogastric Cancer | ||
| 1:25 PM | 0:05 | 1:30 PM | Post-Test Survey, Discussion, and Concluding Remarks | ||
Faculty, Staff, and Planners’ Disclosures
The staff of Physicians’ Education Resource®, LLC, have no relevant financial relationships with ineligible companies.
PER® mitigated all COI for faculty, staff, and planners prior to the start of this activity by using a multistep process.
Off-Label Disclosure and Disclaimer
This activity may or may not discuss investigational, unapproved, or off-label use of drugs. Learners are advised to consult prescribing information for any products discussed. The information provided in this accredited activity is for continuing education purposes only and is not meant to substitute for the independent clinical judgment of a health care professional relative to diagnostic, treatment, or management options for a specific patient’s medical condition. The opinions expressed in the content are solely those of the individual faculty members and do not reflect those of PER® or any company that provided commercial support for this activity.
